Dark Classics in Chemical Neuroscience: Mescaline
Open accessThe DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
Archeological studies in the United States, Mexico, and Peru suggest that mescaline, as a cactus constituent, has been used for more than 6000 years. Although it is a widespread cactus alkaloid, it is present in high concentrations in few species, notably the North American peyote ( Lophophora williamsii ) and the South American wachuma ( Trichocereus pachanoi, T. peruvianus, and T. bridgesii ). Spanish 16th century chroniclers considered these cacti “diabolic”, leading to their prohibition, but their use persisted to our days and has been spreading for the last 150 years. In the late 1800s, peyote attracted scientific attention; mescaline was isolated, and its role in the psychedelic effects of peyote tops or “mescal buttons” was demonstrated. Its structure was established by synthesis in 1929, and alternative routes were developed, providing larger amounts for pharmacological and biosynthetic research. Although its effects are attributed mainly to its action as a 5-HT 2A serotonin receptor agonist, mescaline binds in a similar concentration range to 5-HT 1A and α 2A receptors. It is largely excreted unchanged in human urine, and its metabolic products are apparently unrelated to its psychedelic properties. Its low potency is probably responsible for its relative neglect by recreational substance users, as the successful search for structure–activity relationships in the hallucinogen field focused largely on finding more potent analogues. Renewed interest in the possible therapeutic applications of psychedelic drugs may hopefully lead to novel insights regarding the commonalities and differences between the actions of individual classic hallucinogens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mescaline (6) binds with rather low affinity (Ki) as an agonist at 5HT1A sites (5 µM), 5HT2A/C (6 µM against [3H]-ketanserin), alpha2 (1.4 µM) and TAAR1 (3.3 µM) receptors [9,43].”
From Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. (2021) · cites this paper as [43]
Citations
Cites
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
Handbook of Psychopharmacology
(1978) · Springer eBooks · doi:10.1007/978-1-4613-4042-3 · Cited by 1,091
Leysen, J. E., Niemegeers, C. J., Van Nueten, J. M., & Laduron, P. M. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14623-3 · Cited by 1,071
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4771-x · Cited by 970
Neural correlates of the LSD experience revealed by multimodal neuroimaging
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., Tagliazucchi, E., Schenberg, E. E., Nest, T., Orban, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518377113 · Cited by 859
Gasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000113 · Cited by 750
Nichols, D. E. (1986) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1986.10472362 · Cited by 563
Research works printed but not linked: 12
- Torres C. M., 2008, Chavín Art, Architecture and Culture, 237
- Sahagún B., Historia General de las Cosas de la Nueva España
- Sharon D., 1972, Flesh of the Gods. The Ritual Use of Hallucinogens, 114
- Cruz-Sánchez G., 1948, Rev. Farmacología Med. Exp., 1, 143
- Gutiérrez-Noriega C., 1050, América Indígena, 10, 215
- Poisson J., 1960, Ann. pharm. franç, 18, 764
- Hulsey D., 2011, J. Bot. Res. Inst. Texas, 5, 677
- Kapadia G. J., 1973, Lloydia, 36, 9
- Prentiss D. W., 1895, Ther. Gazette, 9, 577
- Ellis H., 1898, Contemp. Rev., 73, 130
- Shulgin A. T., 1991, PIHKAL, Phenethylamines I Have Known and Loved. A Chemical Love Story
- Alles G. A., 1957, Neuropharmacology, Trans. 4th Conf.
Cited by
The promises and perils of psychedelic pharmacology for psychiatry
McClure-Begley, T. D., & Roth, B. L. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00421-7 · Cited by 194
General and specialized tyrosine metabolism pathways in plants
Xu, J.-J., Fang, X., Li, C., Yang, L., & Chen, X. (2019) · aBIOTECH · doi:10.1007/s42994-019-00006-w · Cited by 152
Dinis-Oliveira, R. J., Pereira, C. L., & da Silva, D. D. (2019) · Current Molecular Pharmacology · doi:10.2174/1874467211666181010154139 · Cited by 100
Mescaline: The forgotten psychedelic
Vamvakopoulou, I. A., Narine, K. A. D., Campbell, I., Dyck, J. R. B., & Nutt, D. J. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109294 · Cited by 121
“Mescaline also binds to the dopamine (DAT), norepinephrine (NET), and serotonin (SERT) transporters but with lower affinity (Table 1) (Páleníček et al., 2008; Kyzar et al., 2012; Rickli et al., 2016; Cassels and Sáez-Briones, 2018).”
BackgroundInfluentialDuan, W., Cao, D., Wang, S., & Cheng, J. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00375 · Cited by 85
Metadata
- Authors
- Cassels, B. K., & Sáez-Briones, P.
- Affiliations
- University of Chile (CL)
- Laboratory of Neuropharmacology and Behavior, School of Medicine, Faculty of Medical Sciences, Universidad de Santiago de Chile, Santiago 9170022, Chile
- Corresponding author
- Cassels, Bruce K.
- ORCID
- Cassels, Bruce K.
- Venue
- ACS Chemical Neuroscience
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-05-30
- Volume
- 9
- Issue
- 10
- Pages
- 2448-2458
- ISSN
- 1948-7193 (ISSN-L)
- OpenAlex
- W2806747726
- Cited by
- 85
- References
- 126
- Citations by year
- 2026: 3 · 2025: 13 · 2024: 12 · 2023: 25 · 2022: 14 · 2021: 11 · 2020: 3 · 2019: 3 · 2018: 1
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by-nc-nd
- Locations
- ACS Chemical Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Universidad de Chile (submittedVersion, cc-by-nc-nd)
- Funders
- Departamento de Investigaciones Cient?ficas y Tecnol?gicas, Universidad de Santiago de Chile (021701SB)
- Fondo Nacional de Desarrollo Cient?fico y Tecnol?gico (1150686)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and bioactivity of alkaloids
- Keywords
- mescaline, peyote, Lophophora williamsii, cactus alkaloids, psychedelics, 5-HT2A receptor agonism, 5-HT1A receptor, alpha2A-adrenergic receptor, structure-activity relationship
- MeSH terms
- Hallucinogens, Humans, Mescaline, Structure-Activity Relationship, History, 16th Century, History, 19th Century, History, 20th Century, History, 21st Century, History, Ancient
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dark Classics in Chemical Neuroscience: Mescaline. https://app.cochat.ai/papers/10.1021/acschemneuro.8b00215
- The paper
- Cassels, B. K., & Sáez-Briones, P. (2018). Dark Classics in Chemical Neuroscience: Mescaline. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.8b00215
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.